Nina Frey

Nina Frey, PhD, is a Discovery Scientist specializing in coagulation, gene therapy, and immunology. With extensive experience in pancreatic and colorectal cancer research, they have applied CRISPR technologies in both in vitro and in vivo systems, leading drug discovery projects and facilitating data-driven decision making. They held a PhD candidacy at ETH Zürich, where they researched pancreatic cancer, and recently served as a Research Project Leader at Roche, focusing on hemophilia and gene therapy. Nina's background also includes undergraduate research roles at the University of Michigan and University of Tübingen, contributing to a strong foundation in biological and biomedical sciences.